ORALE TERPENCYCLODEXTRIN-EINSCHLUSSKOMPLEXVEHIKEL

European patent · EP4125830 · Deleted

Register entry

Publication number
EP4125830
Application number
EP21774359
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 23, 2021
Published
Feb 8, 2023
Granted
Oct 15, 2025
Deleted
Oct 23, 2026
Reason
Annual fee unpaid
IPC classes
A61K 9/48 (2006.01)
A61P 11/12 (2006.01)
A61K 31/045 (2006.01)
A61K 31/05 (2006.01)
A61K 38/00 (2006.01)
A61K 36/15 (2006.01)
A61K 36/48 (2006.01)
A61K 36/534 (2006.01)
A61K 36/61 (2006.01)
A61P 11/10 (2006.01)
A61K 31/015 (2006.01)
A61K 31/07 (2006.01)
A61K 31/352 (2006.01)
A61K 31/58 (2006.01)
A61K 31/724 (2006.01)
Priority
US 202062993346 P 23.03.2020
PCT application
PCT/IB2021/052411 23.03.2021
PCT publication
WO2021/191803 30.09.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 23, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2026

  2. Aug 26, 2026

    Change

    Published in Swissreg on 26.08.2026

  3. Oct 15, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.10.2025

Parties

Holder

Czap Research And Development, LLC

Napa, California 94558, US

Inventor

CZAP, Al

Napa, California 94558, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.